The eyes are a window into the brain for many disorders, and Alzheimer’s disease may be no exception, a researcher said here. In a pilot study, retinal scans to measure blood vessel thickness at the back of the eye showed strong correlations with the l…
Category: News
In A Surprising Finding, Vitamin C Is Found To Prolong Proper Functioning Of Retinal Cells
Nerve cells in the eye require vitamin C in order to function properly – a surprising discovery that may mean vitamin C is required elsewhere in the brain for its proper functioning, according to a study by scientists at Oregon Health & Science Univers…
Optovue Announces FDA 510(k) Clearance for iStandT
Optovue, a pioneer in spectral-domain optical coherence tomography (SD-OCT), announces that the new iStand, a multi-directional stand for universal positioning of the iVue SD-OCT system, received FDA 510(k) clearance in June.
IOP Drop In First Eye After SLT May Predict Drop In Fellow Eye
For patients treated with selective laser trabeculoplasty, IOP reduction percentages in the first eye at 3 months may predict responses in the fellow eye for up to 30 months for those with ocular hypertension and up to 9 months for those with primary o…
Optovue Announces FDA 510(k) Clearance for iStandT
Optovue, a pioneer in spectral-domain optical coherence tomography (SD-OCT), announces that the new iStand, a multi-directional stand for universal positioning of the iVue SD-OCT system, received FDA 510(k) clearance in June.
OHSU Scientists Discover New Role For Vitamin C In The Eye — and The Brain
Portland, Ore. – Nerve cells in the eye require vitamin C in order to function properly – a surprising discovery that may mean vitamin C is required elsewhere in the brain for its proper functioning, according to a study by scientists at Oregon Health …
Optovue Announces FDA 510(k) Clearance for iStandT
Optovue, a pioneer in spectral-domain optical coherence tomography (SD-OCT), announces that the new iStand, a multi-directional stand for universal positioning of the iVue SD-OCT system, received FDA 510(k) clearance in June.
Retinal Imaging And Frequency Of Falls May Point To Early Alzheimer’s
Individuals with Alzheimer’s disease are much more likely to suffer falls compared to other individuals, researchers from Washington University in St. Louis explained at the AAIC 2011 (Alzheimer’s Association® International Conference)…
ICAD: Eyes Spot Early Alzheimer’s (CME/CE)
PARIS (MedPage Today) — The eyes are a window into the brain for many disorders, and Alzheimer’s disease may be no exception, a researcher said here.
Scientists discover new role for vitamin C in the eye and the brain
Nerve cells in the eye require vitamin C in order to function properly — a surprising discovery that may mean vitamin C is required elsewhere in the brain for its proper functioning, according to a new study.
NICE FAD does not recommend ranibizumab for treatment of diabetic macular oedema
Source: NICE
Area: News
The National Institute for Health and Clinical Excellence (NICE) has issued its Final Appraisal Determination (FAD) on ranibizumab for the treatment of diabetic macular oedema (DMO). Within the FAD, ranibizumab is not recommend…
NETAG supports use of intravitreal bevacizumab for the management of age-related macular degeneration
Source: NETAG
Area: Evidence > Drug Specific Reviews
The North East Treatment Advisory Group (NETAG) has produced an updated appraisal of bevacizumab for the management of neovascular age-related macular degeneration and recommended bevacizumab 1.25 …
NICE Turns Down Lucentis (Ranibizumab) For Diabetic Macular Edema Treatment, UK
NICE (National Institute for Clinical Excellence) in the UK has decided not to recommend Lucentis (ranibizumab) for diabetic macular edema (British spelling: oedema) treatment. NICE approves or turns down treatments that will be covered by the NHS (Nat…
PowerVision Adds Medtronic as a Strategic Investor
PowerVision, Inc., a private company developing an accommodating intraocular lens, announced that it had added Medtronic to its list of investors in a recent closing of its Series C financing. Stephen Oesterle, MD, Senior Vice President, Medicine and T…
Novartis Fails to Win UK Backing for Lucentis in Diabetic Eye Condition
Novartis AG, Europes second-largest drugmaker, failed to win approval from the U.K.s health-cost agency for its drug Lucentis in diabetics who suffer an eye condition. Lucentis wasnt cost effective in patients with macular edema, the National Institute…
Eye Tracking Of Infants Reveals Speed Limit On Babies’ Vision
Babies have far less ability to recognize rapidly changing images than adults, according to research from the UC Davis Center for Mind and Brain. The results show that while infants can perceive flicker or movement, they may not be able to identify the…
Optimizing Eyesight: New System For Measuring And Improving Human Vision
With research and development assistance from the Georgia Tech Research Institute (GTRI) and seed funding from the Georgia Research Alliance (GRA), an Atlanta-based company is developing what it hopes will be the next-generation instrument for optimizi…
Novel bionic eyes for the blind in the making
British scientists have developed the first pair of bionic glasses that could help thousands of legally blind people. These glasses using tiny cameras and software technology from video games, alert the wearer to objects in their surroundings using fla…
Vitamin C From Food Tied To Lower Cataract Risk
Older adults who get very little vitamin C in their diets may have an increased risk of developing cataracts, a study in India finds.
New Human Embryonic Stem Cell Study For Dry AMD And Stargardt’s Macular Dystrophy
Two patients have been treated using RPE (retinal pigment epithelial) cells derived from hESCs (human embryonic stem cells) in two Phase 1/2 clinical trials for dry age-related macular degeneration and Stargardt’s macular dystrophy, Advanced Cell Techn…